CardioGenics Holdings Inc (CGNH)
USD 0.0
(99.0%)
USD 0.0
(99.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2015 | 231.93 Thousand USD | -14.08% |
| 2014 | 269.93 Thousand USD | -50.74% |
| 2013 | 547.95 Thousand USD | 43.44% |
| 2012 | 382.01 Thousand USD | -86.62% |
| 2011 | 2.85 Million USD | 14.81% |
| 2010 | 2.48 Million USD | -13.89% |
| 2009 | 2.88 Million USD | 551.61% |
| 2008 | 443.09 Thousand USD | 229.81% |
| 2007 | 134.34 Thousand USD | -76.77% |
| 2006 | 578.23 Thousand USD | -31.01% |
| 2005 | 838.1 Thousand USD | 65.18% |
| 2004 | 507.37 Thousand USD | -5.63% |
| 2003 | 537.65 Thousand USD | 258.64% |
| 2002 | 149.91 Thousand USD | -74.99% |
| 2001 | 599.42 Thousand USD | -85.94% |
| 2000 | 4.26 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2016 Q1 | 558.44 Thousand USD | 140.78% |
| 2015 Q1 | 272.19 Thousand USD | 0.84% |
| 2015 Q4 | 231.93 Thousand USD | -1.28% |
| 2015 FY | 231.93 Thousand USD | -14.08% |
| 2015 Q3 | 234.94 Thousand USD | 2.49% |
| 2015 Q2 | 229.23 Thousand USD | -15.78% |
| 2014 Q4 | 269.93 Thousand USD | -8.75% |
| 2014 FY | 269.93 Thousand USD | -50.74% |
| 2014 Q1 | 409.63 Thousand USD | -25.24% |
| 2014 Q2 | 286.53 Thousand USD | -30.05% |
| 2014 Q3 | 295.79 Thousand USD | 3.23% |
| 2013 FY | 547.95 Thousand USD | 43.44% |
| 2013 Q2 | 519.66 Thousand USD | 16.24% |
| 2013 Q4 | 547.95 Thousand USD | -16.05% |
| 2013 Q3 | 652.74 Thousand USD | 25.61% |
| 2013 Q1 | 447.04 Thousand USD | 17.02% |
| 2012 Q4 | 382.01 Thousand USD | -26.6% |
| 2012 Q3 | 520.47 Thousand USD | -30.83% |
| 2012 FY | 382.01 Thousand USD | -86.62% |
| 2012 Q1 | 833.46 Thousand USD | -70.8% |
| 2012 Q2 | 752.46 Thousand USD | -9.72% |
| 2011 FY | 2.85 Million USD | 14.81% |
| 2011 Q4 | 2.85 Million USD | 94.7% |
| 2011 Q3 | 1.46 Million USD | -22.97% |
| 2011 Q2 | 1.9 Million USD | -15.37% |
| 2011 Q1 | 2.24 Million USD | -9.55% |
| 2010 FY | 2.48 Million USD | -13.89% |
| 2010 Q3 | 1.31 Million USD | -30.54% |
| 2010 Q4 | 2.48 Million USD | 89.38% |
| 2010 Q1 | 2.35 Million USD | -18.42% |
| 2010 Q2 | 1.88 Million USD | -19.77% |
| 2009 Q1 | 229.88 Thousand USD | -59.66% |
| 2009 FY | 2.88 Million USD | 551.61% |
| 2009 Q4 | 2.88 Million USD | -82.22% |
| 2009 Q3 | 16.23 Million USD | 5134.26% |
| 2009 Q2 | 310.18 Thousand USD | 34.93% |
| 2008 Q2 | 299.29 Thousand USD | -45.61% |
| 2008 FY | 443.09 Thousand USD | 229.81% |
| 2008 Q4 | 569.81 Thousand USD | 28.6% |
| 2008 Q3 | 443.09 Thousand USD | 48.04% |
| 2008 Q1 | 550.31 Thousand USD | -3.24% |
| 2007 Q1 | 173.52 Thousand USD | -37.68% |
| 2007 Q2 | 126.51 Thousand USD | -27.09% |
| 2007 Q4 | 568.74 Thousand USD | 323.34% |
| 2007 Q3 | 134.34 Thousand USD | 6.19% |
| 2007 FY | 134.34 Thousand USD | -76.77% |
| 2006 FY | 578.23 Thousand USD | -31.01% |
| 2006 Q4 | 278.42 Thousand USD | -51.85% |
| 2006 Q1 | 236.68 Thousand USD | -53.22% |
| 2006 Q2 | 125.87 Thousand USD | -46.82% |
| 2006 Q3 | 578.23 Thousand USD | 359.36% |
| 2005 Q4 | 505.97 Thousand USD | -39.63% |
| 2005 FY | 838.1 Thousand USD | 65.18% |
| 2005 Q2 | 1.15 Million USD | 582.17% |
| 2005 Q3 | 838.1 Thousand USD | -27.37% |
| 2005 Q1 | 169.16 Thousand USD | -45.24% |
| 2004 FY | 507.37 Thousand USD | -5.63% |
| 2004 Q4 | 308.93 Thousand USD | -39.11% |
| 2004 Q3 | 507.37 Thousand USD | -48.89% |
| 2004 Q2 | 992.61 Thousand USD | 302.4% |
| 2004 Q1 | 246.67 Thousand USD | -11.89% |
| 2003 Q3 | 537.65 Thousand USD | 13.4% |
| 2003 Q4 | 279.95 Thousand USD | -47.93% |
| 2003 Q2 | 474.1 Thousand USD | -55.41% |
| 2003 FY | 537.65 Thousand USD | 258.64% |
| 2003 Q1 | 1.06 Million USD | 65.09% |
| 2002 Q4 | 643.99 Thousand USD | 329.57% |
| 2002 Q1 | 315.13 Thousand USD | -46.51% |
| 2002 Q2 | 216.34 Thousand USD | -31.35% |
| 2002 Q3 | 149.91 Thousand USD | -30.71% |
| 2002 FY | 149.91 Thousand USD | -74.99% |
| 2001 Q2 | 1.29 Million USD | -53.61% |
| 2001 FY | 599.42 Thousand USD | -85.94% |
| 2001 Q1 | 2.78 Million USD | -24.37% |
| 2001 Q4 | 589.08 Thousand USD | -1.72% |
| 2001 Q3 | 599.42 Thousand USD | -53.66% |
| 2000 Q3 | 4.26 Million USD | 12.82% |
| 2000 Q2 | 3.77 Million USD | -29.77% |
| 2000 Q1 | 5.38 Million USD | 0.0% |
| 2000 FY | 4.26 Million USD | 0.0% |
| 2000 Q4 | 3.68 Million USD | -13.52% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | 81.723% |
| Arrayit Corporation | 1 Million USD | 76.816% |
| Atlantic International Corp. | 4.43 Million USD | 94.772% |
| Biocept, Inc. | 30.87 Million USD | 99.249% |
| Bioqual, Inc. | 56.58 Million USD | 99.59% |
| DermTech, Inc. | 121.93 Million USD | 99.81% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.994% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 98.695% |
| iMD Companies, Inc. | 190.13 Thousand USD | -21.982% |
| IDenta Corp. | 1.52 Million USD | 84.834% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 98.219% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 97.189% |
| InVitro International | 1.53 Million USD | 84.881% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 99.136% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -9931.661% |
| Medical Imaging Corp. | 4.19 Million USD | 94.467% |
| NovelStem International Corp. | 2.25 Million USD | 89.713% |
| Optigenex Inc. | 1.88 Million USD | 87.717% |
| PharmChem, Inc. | 2.76 Million USD | 91.614% |
| Proteome Sciences plc | 14.58 Million USD | 98.41% |
| Response Genetics, Inc | 48.88 Million USD | 99.526% |
| Rennova Health, Inc. | 20.57 Million USD | 98.873% |
| RushNet, Inc. | 6.04 Million USD | 96.165% |
| ScreenPro Security Inc. | 1.26 Million USD | 81.613% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | 50.906% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | 66.898% |
| Todos Medical Ltd. | 15.26 Million USD | 98.481% |